Connect with us

Emerging Markets

Luokung Technolgy Corp and FingerMotion 2 Big Data Plays Immune from Didi Global’s (NASDAQ: DIDI) Chinese Contagion

Published

2 years ago

on

didi Global big Data

Government crackdowns in China have had a big negative spillover effect on many Chinese stocks.  DiDi Global (NASDAQ: DIDI) has been acting as a proxy for the rest of the Chinese stocks.  Chinese stocks listed in the U.S. are getting pummeled on security and data-privacy concerns.  Big Data and Chinese stock went into a tailspin after the Cyberspace Administration of China took down Didi’s main app on Independence Day “pending a cybersecurity review.”  The timing of the takedown was one week after its IPO debut and just happened to be on July 4th.  It doesn’t take a detective to figure out politics was in play.  The focus of this article is on 2 Chinese Big Data stocks that are immune from this regulatory risk and were brought down without any thought to the fundamentals.  The key test of Chinese data immunity lies in who owns the data versus who processes the data.  Eventually stocks will decouple and the ones with the strongest fundamentals will rise again.  

Luokung Technology – Leader in Mapping Technology

Luokung Technology (LKCO) is known for its “spatial-temporal big data ” which is really the study of objects or in this case vehicles moving around the city.  Their data is primarily used by ride hailing services.  This means they need to account for vehicle movements, traffic around the vehicle, obstacles, and the movement of people during the planned pickup. The company has also developed a smart city concept that ties traffic, emergency services, delivery, mass transit, and even road repairs into one map that seeks to optimize the movement within the city factoring different priorities like emergency services when they are needed.  A future facet of their business is autonomous driving which will have to factor in not only other vehicles, but pedestrian movements.  If all vehicles have a common interface and are interconnected there can be a general awareness between vehicles allowing everyone to stay safe.  The most difficult part of determining a universal map that consists of cars and pedestrians is connecting to the Internet of Things (IoT) to assist in confirming and predicting pedestrian movement.  The universal driver behind each of their business segments is big data.    

Investor Presentation – BigData Hub Concept

Many data feeds from their digital partners who own and store the data feed into a centralized server where they are dissected, interpreted, and prioritized.  From these data feeds they are able to render a multilayer dimensional map (see below). From this map they are able to generate predictive algorithms capable of figuring the optimal route factoring in traffic.

In essence the company provides DaaS (Data as a Service), SaaS (Software as a Service), PaaS (Platform as a Service), and combinations in between.  Saleya Holdings (eMapgo) which was purchased for $120 million on August 28, 2019 has 3 main revenue stream classifications.  They have map data services, autonomous driving map data services, and in-dash navigation.  

The revenues of the subsidiary are modest at the moment, but represent an enormous emerging market and almost a pure play on the autonomous driving market segment.

The mobile application known as Luokung is primarily a Business to Customer (B2C) situation that utilizes railroad-WiFi in concert with its software apps to provide tailored content that contains relevant information, entertainment, travel, and e-commerce to the long distance rail rider.  The guiding principle behind the service that has over 51 million users is to reduce boredom on the trains and push the idea of discovering new things to do upon arrival.  Advertising is a key component of their model that includes online to offline (O2O) which hopes to engage passengers while enroute, to purchase or do something once they arrive at their destination.  Recommendations are based on users interests which include restaurants, entertainment, accommodations, local snacks, local products, scenic spots, or points of historical significance.  

The Grecent deal with Tencent Holdings (OTCMKTS: TECHY) initially expanded the base of passengers and increased revenue per customer because high-speed rail customers typically spend more.  This eventually morphed into Luokung Location-based Services (LBS) Data Marketing Platform that is a combination of advertising and very detailed maps, points of interest, 20,000 commercial buildings, train stations, shopping malls, and airports.     

They also have Business to Business (B2B) and Business to Government (B2G) services.  These programs operate in real time allowing the business customers like ride hailing services to predict pickup and drop off points and arrival and departure times with greater accuracy. Smart cities seek to control the port of entry, traffic monitoring, and logistical movement using proprietary systems covered by patents and copyrights that allow for the transmission and rendering of extremely detailed maps that are graphically optimized to operated in a low bandwidth infrastructure while bringing the equivalency of terabytes of data.  

Financial Performance

The company has high R&D expenses and high marketing expenses because they operate in a state of continuous improvement in order to keep customers satisfied and retained on their platforms.  The focus of their efforts are on additional features and performance enhancements while at the same time expanding markets and acquiring business or technology that fits. Notes 4&5 in the cost of revenues was primarily intercompany receivables and amortization of intangible assets which serve to only weaken the earnings outlook only in the short run.  .    

LKCO currently has a market capitalization of $515 million and has 318 million shares outstanding.  The company made 3 offerings in 2021 and brought in about $120 million in cash.  They also completed the acquisition of Saleya on March 17, 2021 for $102 million in cash.  They also have strong backing from Geely, a large Chinese car manufacturer and other notable entities and wide industry connections not to mention their cooperation deals with Beidou positioning, Dell, and National Goepspatial.  

Busy Start / Future Catalysts

March: LKCO announced the acquisition of 100% equity interest in EMG, the first-class mapping company. Following the Company’s successful financing of US$120 million, LKCO has completed the acquisition, which has become a wholly owned subsidiary of the Company.

April: The company received a notification letter from Nasdaq stating that it has regained compliance with the requirement rule of minimum bid price in 5550(a)(2).

May: LKCO obtained the contract which is about the new traffic control system and Intelligent Road.
July: It announced a formal strategic cooperation agreement with the National Geospatial Information Center (NGIC) in a range of sectors including geospatial information services. Besides, recently LKCO revealed that it will cooperate with one of the top China’s automakers collecting and managing the data of autonomous driving vehicles.

The stage is set for more acquisitions around the core mapping technology.  They are also winning more contracts in government and with car manufacturers which will boost the financial outlook and perhaps generate the cash they need for more acquisitions.  Processed data is what they sell and it’s quite valuable but the raw data is not something they own.  This is why they are immune to government crackdowns.  The drop in stock price was completely unrelated to government regulation and people will eventually understand that these autonomous cars will need virtual drivers and when they do only a few players in the world like LKCO will be able to take the wheel.  

FingerMotion – Leading InsureTech Player

FNGR has 3 primary business silos.  They have a mobile data and recharge platform, an SMS and MMS payment solutions, and their big data solutions wrapped up in their subsidiary called Sapientus.  These silos are all interconnected because FNGR has direct access to the mobile carriers.  This gives them an unprecedented number of users that can be converted into buying goods and services that FingerMotion is reselling. This availability of user metadata helps them create extremely accurate algorithms that can better predict user behavior in its Big Data arm.


Top Up & Mobile Recharge

The company started in the Top up and mobile recharge business.  In the United States most cell phones are on monthly plans that are paid after usage, but in China the phones add minutes or data in incremental amounts.  FingerMotion has the wholesale license to sell Top up minutes from China Mobile and China Unicom which are the largest telecoms in China, to e-commerce platforms that include AliBaba (NASDAQ: BABA), PingDuoDuo (NASDAQ: PDD), and JD.com (NYSE: JD). These e-commerce platforms have well over a billion users and allow FNGR to market Top up minutes to their respective user bases.  FNGR gets a small sliver of millions of transactions daily.  Their margins are quite thin, but they have no marketing expenses and don’t have to spend money to retain customers like the e-commerce platforms do.  

SMS & MMS

The SMS and MMS business are responsible for most of the gross profit and has been one of the fastest growing business silos in the company.  

 

Big Data

The Big Data business is held in the subsidiary Sapientus.  It is run by a team of seasoned actuaries and data scientists with a specialty in creating algorithms. The life blood of the insurance industry comes down to risk analysis.  The developing insuretec business at Sapientus is driving innovation in the insurance business that enables the real time assessment of an individual based on risk scoring.  They currently have big data agreements with Pacific Life Re and Happy Life Insurance with many more on the way.  

The algorithms developed by their big data research team take many personal factors into account.  However, the data that goes into these algorithms is from non-identifiable people whose information resides on the host server where the data was sourced from.  Think of it as taking a personal profile and instantly type casting them so that they fit into many different molds like a fitness fanatic or a video gamer.  

Their personal identity is lost but their behaviors and what they typically do are turned into an algorithm that uses distributional statistics and cluster variables that would mimic their actual behavior. Insurance risk algorithms would assign risk scores to these behavioral profiles so when queried in real time, that particular individual would be matched against a behavioral profile that was already assigned a risk score and can be immediately quoted.  

The behavioral analytics also have far reaching consequences inside and outside the insurance business.  For example, another application within the field of insurance is fraud detection to ensure the claims match up to the risk profile.  Outside the insurance sector, big data can profile people seeking credit or financial services which represent a huge untapped market due to the unavailability of credit scores in China.  Morphing into the largest credit scoring reporter in China means FNGR could eventually challenge Visa (NYSE: V) or MasterCard (NYSE: MA), American Express (NYSE: AXP) or PayPal (NASDAQ: PYPL) and become a ripe acquisition target for one of these behemoths.  

In fact FNGR should be able to do anything big data provider Snowflake (NASDAQ: SNOW) can do because SNOW is focused behavior around product sales of merchandise while FNGR is more focused on the consumer who is infinitely more complicated.  FNGR uses practically the same structure as SNOW just liess the centralized storage of data. If SNOW was looking toward international expansion FNGR would be on the short list.  When considering the $78 billion market cap of SNOW versus the $120 million FNGR, FNGR might not last even a year on the NASDAQ before they get gobbled up for their unparalleled access to all of China.  

Heavily Shorting the Macro Without Paying Attention to Core Fundamentals

Both stocks FingerMotion and Luokung Technology have active shorts.  The shorts expect continued sector weakness and they have literally done no due diligence on these names.  LKCO has had its short interest rise from 69K to 8.7 million shares in just the past 6 months.  Average daily volume has exploded to 16.5 million.  The short volume is much harder to see in FNGR because it’s traded in the OTC market.  There are 4.2 million shares held at DTC and only 750,000 shares are held by retail as evidenced by the average volume of 20,000 shares traded daily.  That’s only 3% turnover of the real float daily.  The smoking gun signature of the short presence in FNGR are large orders that have been pummeling the bid in quick succession.  

Investment Summary

The market is playing the guilt by association game when it comes to Chinese big data plays.  Any Chinese company that collects, stores, or owns personal data seems to be a target.  Since Chinese companies are not really that well covered or known for their transparency, shorts are pounding on names hoping to play on investors fears that they don’t understand the fundamentals of the business.  This has created an enormous opportunity in a couple of e-commerce and big data plays growing extremely quickly and quietly in China.  Most notably are LKCO and FNGR.  Both of these companies are provided with Big Data and then analyze and manipulate into something that is actionable by the user.  They DON’T OWN THE DATA so they are immune from government intervention.  

Whether it’s finding out where your pickup location is scheduled or an optimized quote on car insurance, Big Data is transforming the lives of the Chinese people.  The Chinese market is enormous so creating disruptive technologies like autonomous drivers or insuretech solutions will catch on and scale very rapidly.  LKCO has invested a tremendous amount into R&D and is on the cusp of monetizing their disruptive solutions to the market.  FNGR is on the verge of rolling out insurtech products that could ultimately transform the Chinese insurance industry and its unthinkable that this name is only worth $120 million when it could completely dominate the insurance market in the coming 2 years.  They are also moving forward with a NASDAQ uplisting that could provide institutional interest that has been lacking while squeezing to shorts to cover their naked positions ahead of the uplisting.        

Disclosure: we hold no position in LKCO or FNGR either long or short and we have not been compensated for this article.

Related Topics:
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Emerging Markets

Lucy Scientific Discovery’s (NASDAQ: LSDI) Game-Changing Move: A Closer Look at the High Times Acquisition

Published

3 weeks ago

on

September 8, 2023

By

On August 8th, 2023, Lucy Scientific Discovery Inc. (NASDAQ: LSDI), a leading developer in the psychedelic drug industry, witnessed an impressive surge in its stock value, gaining approximately 25% in combined trading, including after-hours (AH) trading. The British Columbia-based company made headlines by announcing its strategic move to acquire intellectual property (IP) from the renowned cannabis publication, High Times Holding Corp. (HHC).

Additional Background:

Under this agreement, Lucy will exchange 20% of its shares and a series of payments for access to HHC’s valuable IP portfolio, which includes the rights to generate licensing and royalty income from renowned brands like High Times, 420.com, and Cannabis Cup, along with their associated domain names.

Lucy’s commitment involves making semi-annual payments to HHC over a five-year period, structured around earnings before income, taxes, depreciation, and amortization (EBITDA) generated through the acquired IP. The flexibility exists for Lucy to fulfill these payments either in cash or through stock issuance and the announcement is generating considerable interest.

Furthermore, post-acquisition, Lucy will grant High Times the opportunity to operate retail outlets and distribute THC products bearing these prestigious brands within the United States. This privilege comes in exchange for an annual license fee of $1 million, set to double to $2 million annually once federal legalization of cannabis occurs in the country.

Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Leveraging the brand rights secured from HHC, Lucy aims to bolster its revenue streams by expanding and enhancing its existing 18 licensing agreements, both domestically and internationally. These arrangements encompass a wide array of consumer products and merchandise, promising to further establish Lucy’s presence in the global market. The acquisition is expected to be finalized within the coming two weeks, marking a significant strategic move for Lucy Scientific Discovery Inc.

As a result of the acquisition, High Times is now a publicly-traded entity. Lucy anticipates that this agreement will contribute over $10 million in revenue to its financial results in the upcoming year, along with $5 million in EBITDA.

Adam Levin, the Executive Chairman of HHC, expressed optimism about the deal, noting, “This transaction will create exciting new growth opportunities for the High Times brand, under the leadership of Richard Nanula, a seasoned executive with extensive experience in major consumer brands and global corporations.”

Levin also emphasized High Times’ enthusiasm in becoming a significant shareholder of Lucy Scientific Discovery. Notably, Lucy completed its initial public offering and Nasdaq listing in February, offering 1,875,000 shares at $4.00 each.

Richard Nanula, CEO of the British Columbia-based company, shared his outlook on the acquisition, stating, “Lucy expects this acquisition to rapidly generate high-margin revenue within the global cannabis sector.”

In recent developments, Lucy introduced the sleep aid product “Twilight,” which includes amanita muscaria and reishi mushrooms. Additionally, the company joined forces with Wesana Health Holdings Inc. (OTCQB: WSNAF) in March to collaborate on the development of the CBD and psilocybin-based drug SANA-013, targeting conditions such as migraines, cluster headaches, and major depressive disorder.

High Times, founded in 1974, has a rich history, featuring works by renowned writers like Truman Capote and Hunter S. Thompson. Since 1988, its Cannabis Cup has stood as the most prestigious cannabis competition globally, with notable judges including Snoop Dogg, Joe Rogan, Tommy Chong, and other prominent figures in the cannabis industry.

While Lucy’s shares showed a nearly 16% increase to reach $0.68 on the Nasdaq exchange on Friday, it is worth noting that they have experienced a decline of over 77% over the past year.

Macro Trend:

In recent times, our articles have prominently featured cannabis-related topics, reflecting the growing popularity of stocks in this sector. LSDI’s acquisition aligns perfectly with the current climate, as the cannabis industry experiences a significant surge, coinciding with the Health and Human Services (HHS) exploring the possibility of reclassifying cannabis from Schedule I to Schedule III of the Controlled Substances Act.

While many countries around the world have already moved towards decriminalization and legalization, the United States has been relatively cautious in its approach. However, the consideration of such a reclassification represents a potential historic turning point. If such a change were to materialize, it would mark a substantial shift in the regulatory landscape, potentially revitalizing cannabis as an attractive investment opportunity. The industry is already showing signs of reestablishing its market presence and could once again become a noteworthy investment option.

We will update you on LSDI when more details emerge, subscribe to Microcapdaily to follow along!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Picture by herbalhemp from Pixabay

 

Continue Reading

Emerging Markets

WM Technology’s (NASDAQ: MAPS) Stock Surges 91% in Mysterious Rally: What’s Behind the Boom?

Published

4 weeks ago

on

September 5, 2023

By

WM Technology’s (NASDAQ: MAPS) stock has exhibited remarkable growth, surging by an impressive 91% since August 16th, 2023. Intriguingly, this surge occurred in the absence of any substantial news or filings from the company, with their most recent release dating back to August 23rd, 2023. This limited information raises the question: What is driving this impressive rally? We will delve into the details below to shed light on the matter.

Cannabis Industry:

If you’ve been following our newsletter, you may have noticed our recent article spotlighting Flora Growth Corp. (NASDAQ: FLGC), along with larger players like Cronos Group Inc. (NASDAQ: CRON), and Canopy Growth Corporation (NASDAQ: CGC).

Subscribe to Microcapdaily.com Right Now by entering your Email in the box below. 

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

In case you haven’t had a chance to read it, you can find the article here, featuring a dedicated section on the broader trends shaping the cannabis industry.

For those seeking a quick summary, a significant development has emerged in the cannabis landscape. A high-ranking official at the Department of Health and Human Services (HHS) has proposed moving cannabis from Schedule I to Schedule III of the Controlled Substances Act. This shift marks a historic moment and comes after a comprehensive yearlong investigation requested by President Biden.

It’s worth noting the potential implications of this change for U.S.-based, plant-touching marijuana companies. Currently, these companies are restricted from trading on major exchanges like the NYSE or NASDAQ and are relegated to smaller markets such as the OTC, or smaller Canadian markets like the TSX, CSE, or NEO.

The CEO of Trulieve Cannabis Corp. (OTC: TCNNF), Kim Rivers delves into these implications in a podcast conversation with a Twitter user known as @stock_mj. She also recommends keeping a close eye on the AdvisorShares Pure US Cannabis ETF (MSOS) as the cannabis sector garners increasing attention from investors.

Weedmap’s Earnings:

To evaluate the potential of MAPS, it’s essential to examine their recent earnings and assess the fundamentals. Here’s a brief overview of the news release.

Revenue: Amounted to $50.9 million, representing a decline compared to the same period in the prior year when it reached $58.3 million.

Net Income: Recorded at $2.0 million for the second quarter of 2023, marking a significant decrease from the previous year’s figure of $19.8 million.

Adjusted EBITDA: Showed substantial improvement, totaling $10.2 million in the second quarter of 2023, as opposed to a negative figure of $(0.6) million in the same period of the prior year.

Cash: As of June 30, 2023, the company held $24.6 million in cash, noteworthy for being entirely debt-free.

WM Technology’s Executive Chair, Doug Francis, underscored the company’s dedication to reinforcing its financial position and delivering sustained growth.

Guidance for the third quarter of 2023:

Revenue: An estimated $47 million.

Non-GAAP Adjusted EBITDA: Approximately $4 million.

It’s important to note that these projections are subject to potential variations based on various factors and developments.

Furthermore, WM Technology announced the transition to Moss Adams LLP as its new independent registered public accounting firm, effective upon the filing of the Quarterly Report on Form 10-Q for the quarter ended June 30, 2023, following the resignation of Baker Tilly US, LLP due to staffing constraints.

Although the company maintains a debt-free status, it’s crucial to recognize that there has been a substantial decline in both revenue and net income. Consequently, it is advisable to exercise caution when considering investment, as the current trajectory of their top-line figures does not exhibit a positive trend.

https://twitter.com/5teelersfan/status/1699102436672299134?s=20

Weedmap’s Strategic Partnership:

Furthermore, the company made another recent announcement regarding its strategic partnership with the producer of “The Freak Brothers,” a celebrated stoner comic series that has captivated audiences for over five decades.

The series follows the adventures of three stoner characters and their cat, who awaken from a 50-year slumber induced by a magical strain of weed in 1969, now navigating life in contemporary San Francisco.

Key highlights of this partnership include in-episode Weedmaps integrations in the upcoming second half of “Freak Brothers” season two, commencing on September 24th. Additionally, exclusive “Smoke & Screen” events will be held across the U.S., bringing together influential figures from both the cannabis and entertainment industries.

“The Freak Brothers” series, based on Gilbert Shelton’s cult classic comic, celebrates its 55th anniversary with a star-studded voice cast for Season 2, featuring Woody Harrelson, John Goodman, Pete Davidson, Tiffany Haddish, Adam Devine, Blake Anderson, Andrea Savage, La La Anthony, ScHoolboy Q, and a special guest appearance by Joe Sikora.

To watch Season 2 of “The Freak Brothers,” visit Tubitv.com, and for cannabis-related information, explore Weedmaps.com. For more on “The Freak Brothers,” visit the official website at www.thefreakbrothers.com.

We will update you on MAPS when more details emerge, subscribe to Microcapdaily to follow along!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Picture by NickyPe from Pixabay.com

Continue Reading

Emerging Markets

Cannabis Industry Surges: Flora Growth Corp. (NASDAQ: FLGC) Leads the Way with 77% Intraday Jump

Published

1 month ago

on

August 31, 2023

By

Flora Growth Corp. (NASDAQ: FLGC) experienced a remarkable intraday surge of over 77%. While the company has made significant announcements recently, today’s surge occurred without any specific filings or press releases to explain it. There seems to be something substantial driving this trading frenzy, a broader force impacting the entire asset class.

It’s worth noting that established industry leaders like Canopy Growth Corporation (NASDAQ: CGC) and Cronos Group Inc. (NASDAQ: CRON) have faced significant downtrends in past years. However, today’s market activity also lifted their stocks along with others. To understand this trend, let’s take a closer look at the larger market dynamics at play.

 

Subscribe to Microcapdaily.com Right Now by entering your Email in the box below. 

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

What Happened:

A top official at the Department of Health and Human Services (HHS) has recommended moving cannabis from Schedule I to Schedule III of the Controlled Substances Act, marking a historic shift. This move follows a comprehensive yearlong investigation requested by President Biden.

https://twitter.com/NotFinancialRep/status/1697189406665245149?s=20

In the short term, this won’t significantly impact the cannabis industry, as the Drug Enforcement Agency (DEA) needs to conduct its own review and the federal prohibition on marijuana remains. However, the HHS recommendation, if followed by the DEA, could happen within a year, possibly before the 2024 presidential election.

Long-term implications for the cannabis industry are uncertain, but a key immediate effect would be the elimination of Section 280e of the IRS tax code for cannabis businesses. This provision currently prevents them from claiming standard business deductions, a major financial burden.

While rescheduling won’t directly open up access to institutional banking, it may attract new capital sources due to reduced risk perception among investors. Smaller banks and lenders might become more willing to engage.

Eliminating 280e could also stimulate lending in an industry with high borrowing costs, as companies would have improved cash flow. This might lead to lower interest rates and greater access to operating and expansion capital.

Rescheduling could benefit publicly traded cannabis companies, potentially enticing more exchanges, like the Toronto Stock Exchange, to accept U.S.-based cannabis businesses. It could also encourage Congress to take further action, such as passing the SAFE Banking Act and broader reforms.

Overall, while the exact implications of rescheduling are uncertain, the HHS announcement signals progress toward a post-prohibition reality for the cannabis industry, which is a significant development.

https://twitter.com/S_Andreoni/status/1697289527180562880?s=20

Having set the stage with the broader cannabis industry context, let’s delve into Flora Growth’s recent developments and their implications for the company’s future. Is Flora Growth strategically positioned to leverage the potential easing of restrictions in the cannabis sector?

European Expansion:

Flora Growth just formed a partnership with TruHC Pharma GmbH, a leading medical cannabis expert based in Hamburg, Germany. TruHC holds key certifications for importing, distributing, and manufacturing medical cannabis and is awaiting an EU-GMP license for its cutting-edge cannabis laboratory.

Hendrik Knopp, a respected legal professional and entrepreneur, and his team from TruHC are joining Flora, bringing their extensive expertise in pioneering medical cannabis in Germany. This partnership is seen as very valuable, especially as Germany and the European Union move towards making medical cannabis more accessible to patients.

Clifford Starke, CEO of Flora, expressed excitement about the collaboration, recognizing the potential to contribute to the growth of the medical cannabis industry as regulations evolve. The partnership aims to capture a significant market share in Germany.

Hulk Hogan Partnership:

Flora Growth also just recently entered an exclusive worldwide partnership with WWE legend Hulk Hogan to launch a range of consumer products through Just Brands. These products will include CBD-infused items like pre-rolls, topicals, edibles, and more, which Flora will produce and sell globally. The partnership aims to capitalize on Hulk Hogan’s iconic status and Flora’s global distribution network. The initial agreement is for three years, with potential renewals, targeting $20 million in sales over the first 24 months. Flora will pay royalties and license fees for Hulk Hogan-branded products.

Conclusion:

In summary, the cannabis industry appears ready for a resurgence, buoyed by renewed investor optimism and shifting market dynamics. Our focus today was Flora Growth Corp. (NASDAQ: FLGC) but larger names like Canopy Growth Corporation (NASDAQ: CGC) and Cronos Group Inc. (NASDAQ: CRON) are among the many companies benefitting from this positive trend.

We will update you on FLGC when more details emerge, subscribe to Microcapdaily to follow along!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Picture by 7raysmarketing from Pixabay

Continue Reading

Trending

© All rights reserved.

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.